RANDOMIZED COMPARISON OF ALTERNATING TRIPLE THERAPY ('ATT') VERUS CHOP IN PATIENTS WITH INTERMEDIATE GRADE LYMPHOMAS AND IMMUNOBLASTIC LYMPHOMAS WITH INTERNATIONAL INDEX 2-5.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Idarubicin; Ifosfamide; Mesna; Methylprednisolone; Mitoxantrone; Prednisone; Vincristine
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 14 Nov 2018 Biomarkers information updated
- 03 Jan 2009 Cisplatin identified as an additional treatment arm as reported by ClinicalTrials.gov.
- 16 Sep 2005 New trial record.